Cargando…
SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition
Thyroid cancer (TC) is one of the most common malignancies involving the head and neck, and its incidences are increasing every year. Small G protein signaling modulators 2 (SGSM2) belongs to a newly identified protein group that contributes to numerous cancer progression. However, its role in TC re...
Autores principales: | Su, Xi, Chen, Dong, Zhu, Lizhang, Jia, Hao, Cai, Jiaxuan, Li, Peng, Han, Bin, Wang, Donglai, Li, Hongtao, Fan, Jiaqian, Gu, Mengwei, Zhou, Yaqi, Guan, Haixia, Wei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907342/ https://www.ncbi.nlm.nih.gov/pubmed/35264562 http://dx.doi.org/10.1038/s41419-022-04598-y |
Ejemplares similares
-
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
por: Li, Junsheng, et al.
Publicado: (2022) -
Vitamin C sensitizes BRAF(V600E) thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032
por: Su, Xi, et al.
Publicado: (2021) -
Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1
por: Wu, Jiansong, et al.
Publicado: (2019) -
Structural basis of inactivation of Ras and Rap1 small GTPases by Ras/Rap1-specific endopeptidase from the sepsis-causing pathogen Vibrio vulnificus
por: Jang, Song Yee, et al.
Publicado: (2018) -
Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer
por: Cui, Guoliang, et al.
Publicado: (2021)